LaNova Australia Pty Limited clinical trials
Acquired by Sino Biopharmaceutical Limited
The registry lists 2 studies whose lead sponsor is LaNova Australia Pty Limited. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 12, 2025.
Registry sponsor names on this page
- LaNova Australia Pty Limited2 studies
Something wrong with this grouping? Tell us on the Sino Biopharmaceutical Limited page.
Studies
Recruiting first, then most recently updated. Showing 2 of 2. All Sino Biopharmaceutical Limited studies →
- Study of LM-108 as a Single Agent or in Combination With Anti-PD-1 Antibody in Subjects With Advanced Solid TumoursCompletedNCT05199753Phase 1/2
Sponsor listed in the registry: LaNova Australia Pty Limited · LaNova Australia Pty Limited — acquired company within the Sino Biopharmaceutical Limited group
- Study of LaNova Medicines(LM)-302 in Combination With Toripalimab in Patients With Advanced Solid TumorsCompletedNCT05188664Phase 1/2
Sponsor listed in the registry: LaNova Australia Pty Limited · LaNova Australia Pty Limited — acquired company within the Sino Biopharmaceutical Limited group